LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Health & Fitness
• Non-Profit & Charity

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cancer, article, pubmed, google, scholar, cas, ccl, research, phase, prostate, carlumab, patients, pienta, protein, res, janssen, study, solid, macrophage, human, tumors, access, monocyte, chemoattractant, clin, development, antibody, ligand, bono, loberg, cell, tumor, johnson, privacy, cookies, content, cnto, monoclonal, ccchemokine, puchalski, seetharam, activity, trials, chemokine, zhang, snyder, van, ying, growth, expression,

Topics {✒️}

adult t-cell leukemia-lymphoma phosphatidylinositol 3-kinase/akt-dependent survivin tumor necrosis factor month download article/chapter facilitate breast-tumour metastasis peripheral t-cell lymphoma cancer clinical trials androgen-independent prostate cancer cc chemokine mcp-1/ccl2 small-cell lung cancer placebo-controlled clinical trial article cancer chemotherapy prostate cancer growth cc-chemokine ligand 2 de bono js monocyte chemoattractant protein-1 full article pdf phase ib study privacy choices/manage cookies human monoclonal antibody squamous cell carcinoma escalating dose administration macrophage chemoattractant protein-1 kunkel sl cancer-related inflammation cancer bone metastases pharmacokinetic–pharmacodynamic profile conducting research sponsored van den bosch preclinical information included human breast cancer janssen biologics monocyte chemotactic solid tumors national cancer institute janssen global services phase 1 trial terminal half-life real world risk front-line obinutuzumab small gtpase rac st john ln destructive cascade mediated common terminology criteria adverse events queen mary university conditions privacy policy christina messiou pharmacology article european economic area

Schema {🗺️}

WebPage:
      mainEntity:
         headline:A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
         description:The CC-chemokine ligand 2 (CCL2) is highly expressed in various malignancies and promotes carcinogenesis. Blocking CCL2 has preclinical antitumor activity. A phase 1 trial of carlumab (CNTO 888), a human anti-CCL2 IgG1κ mAb, was conducted to evaluate the safety, tolerability, pharmacokinetic–pharmacodynamic profile, and antitumor activity. Patients with advanced solid malignancy received escalating doses of carlumab 0.3, 1, 3, 10, or 15 mg/kg by 90-min intravenous infusion on days 1, 28, and every 2 weeks thereafter (dose escalation) or 10 or 15 mg/kg every 2 weeks (dose-expansion). Pharmacodynamic assessments were also performed. Forty-four patients received 206 doses of carlumab. MTD was not established. Carlumab-related adverse events included grade 1–2 fatigue (9 %), nausea (7 %), headache (7 %), vomiting (5 %), and pruritus (5 %). The recommended phase II dose was 15 mg/kg every 2 weeks. Carlumab concentrations declined bi-exponentially with a terminal half-life of 6.6–9.6 days. Free CCL2 was transiently suppressed, while total CCL2 increased dose-dependently >1,000-fold post-treatment. A patient with ovarian cancer and a patient with prostate cancer achieved CA125 and PSA reductions of >50 % and RECIST SD for 10.5 and 5 months, respectively. Two other patients had RECIST SD for 7.2 and 15.7 months. Carlumab was well tolerated with evidence of transient free CCL2 suppression and preliminary antitumor activity.
         datePublished:2013-02-06T00:00:00Z
         dateModified:2013-02-06T00:00:00Z
         pageStart:1041
         pageEnd:1050
         sameAs:https://doi.org/10.1007/s00280-013-2099-8
         keywords:
            Carlumab
            CC-chemokine ligand 2
            CC-chemokine receptor 2
            Phase I
            Solid tumors
            Oncology
            Pharmacology/Toxicology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-013-2099-8/MediaObjects/280_2013_2099_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-013-2099-8/MediaObjects/280_2013_2099_Fig2_HTML.gif
         isPartOf:
            name:Cancer Chemotherapy and Pharmacology
            issn:
               1432-0843
               0344-5704
            volumeNumber:71
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Shahneen K. Sandhu
               affiliation:
                     name:The Institute of Cancer Research
                     address:
                        name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kyri Papadopoulos
               affiliation:
                     name:START Center for Cancer Care
                     address:
                        name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter C. Fong
               affiliation:
                     name:The Institute of Cancer Research
                     address:
                        name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Amita Patnaik
               affiliation:
                     name:START Center for Cancer Care
                     address:
                        name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christina Messiou
               affiliation:
                     name:The Institute of Cancer Research
                     address:
                        name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David Olmos
               affiliation:
                     name:The Institute of Cancer Research
                     address:
                        name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:George Wang
               affiliation:
                     name:Biostatistics, Janssen Research & Development
                     address:
                        name:Biostatistics, Janssen Research & Development, Spring House, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Brenda J. Tromp
               affiliation:
                     name:Oncology, Janssen Biologics, B.V.
                     address:
                        name:Oncology, Janssen Biologics, B.V., Leiden, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas A. Puchalski
               affiliation:
                     name:Janssen Research & Development
                     address:
                        name:Biologics Clinical Pharmacology, Janssen Research & Development, Spring House, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frances Balkwill
               affiliation:
                     name:Queen Mary University of London
                     address:
                        name:Barts Cancer Institute, Queen Mary University of London, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Birge Berns
               affiliation:
                     name:Global Regulatory Affairs
                     address:
                        name:Global Regulatory Affairs, High Wycombe, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shobha Seetharam
               affiliation:
                     name:Janssen Research & Development
                     address:
                        name:Biomarker Oncology, Janssen Research & Development, Spring House, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Johann S. de Bono
               affiliation:
                     name:The Institute of Cancer Research
                     address:
                        name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Anthony W. Tolcher
               affiliation:
                     name:START Center for Cancer Care
                     address:
                        name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
      description:The CC-chemokine ligand 2 (CCL2) is highly expressed in various malignancies and promotes carcinogenesis. Blocking CCL2 has preclinical antitumor activity. A phase 1 trial of carlumab (CNTO 888), a human anti-CCL2 IgG1κ mAb, was conducted to evaluate the safety, tolerability, pharmacokinetic–pharmacodynamic profile, and antitumor activity. Patients with advanced solid malignancy received escalating doses of carlumab 0.3, 1, 3, 10, or 15 mg/kg by 90-min intravenous infusion on days 1, 28, and every 2 weeks thereafter (dose escalation) or 10 or 15 mg/kg every 2 weeks (dose-expansion). Pharmacodynamic assessments were also performed. Forty-four patients received 206 doses of carlumab. MTD was not established. Carlumab-related adverse events included grade 1–2 fatigue (9 %), nausea (7 %), headache (7 %), vomiting (5 %), and pruritus (5 %). The recommended phase II dose was 15 mg/kg every 2 weeks. Carlumab concentrations declined bi-exponentially with a terminal half-life of 6.6–9.6 days. Free CCL2 was transiently suppressed, while total CCL2 increased dose-dependently >1,000-fold post-treatment. A patient with ovarian cancer and a patient with prostate cancer achieved CA125 and PSA reductions of >50 % and RECIST SD for 10.5 and 5 months, respectively. Two other patients had RECIST SD for 7.2 and 15.7 months. Carlumab was well tolerated with evidence of transient free CCL2 suppression and preliminary antitumor activity.
      datePublished:2013-02-06T00:00:00Z
      dateModified:2013-02-06T00:00:00Z
      pageStart:1041
      pageEnd:1050
      sameAs:https://doi.org/10.1007/s00280-013-2099-8
      keywords:
         Carlumab
         CC-chemokine ligand 2
         CC-chemokine receptor 2
         Phase I
         Solid tumors
         Oncology
         Pharmacology/Toxicology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-013-2099-8/MediaObjects/280_2013_2099_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-013-2099-8/MediaObjects/280_2013_2099_Fig2_HTML.gif
      isPartOf:
         name:Cancer Chemotherapy and Pharmacology
         issn:
            1432-0843
            0344-5704
         volumeNumber:71
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Shahneen K. Sandhu
            affiliation:
                  name:The Institute of Cancer Research
                  address:
                     name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kyri Papadopoulos
            affiliation:
                  name:START Center for Cancer Care
                  address:
                     name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter C. Fong
            affiliation:
                  name:The Institute of Cancer Research
                  address:
                     name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Amita Patnaik
            affiliation:
                  name:START Center for Cancer Care
                  address:
                     name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christina Messiou
            affiliation:
                  name:The Institute of Cancer Research
                  address:
                     name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David Olmos
            affiliation:
                  name:The Institute of Cancer Research
                  address:
                     name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:George Wang
            affiliation:
                  name:Biostatistics, Janssen Research & Development
                  address:
                     name:Biostatistics, Janssen Research & Development, Spring House, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Brenda J. Tromp
            affiliation:
                  name:Oncology, Janssen Biologics, B.V.
                  address:
                     name:Oncology, Janssen Biologics, B.V., Leiden, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas A. Puchalski
            affiliation:
                  name:Janssen Research & Development
                  address:
                     name:Biologics Clinical Pharmacology, Janssen Research & Development, Spring House, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frances Balkwill
            affiliation:
                  name:Queen Mary University of London
                  address:
                     name:Barts Cancer Institute, Queen Mary University of London, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Birge Berns
            affiliation:
                  name:Global Regulatory Affairs
                  address:
                     name:Global Regulatory Affairs, High Wycombe, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shobha Seetharam
            affiliation:
                  name:Janssen Research & Development
                  address:
                     name:Biomarker Oncology, Janssen Research & Development, Spring House, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Johann S. de Bono
            affiliation:
                  name:The Institute of Cancer Research
                  address:
                     name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Anthony W. Tolcher
            affiliation:
                  name:START Center for Cancer Care
                  address:
                     name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Chemotherapy and Pharmacology
      issn:
         1432-0843
         0344-5704
      volumeNumber:71
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The Institute of Cancer Research
      address:
         name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
         type:PostalAddress
      name:START Center for Cancer Care
      address:
         name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
         type:PostalAddress
      name:The Institute of Cancer Research
      address:
         name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
         type:PostalAddress
      name:START Center for Cancer Care
      address:
         name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
         type:PostalAddress
      name:The Institute of Cancer Research
      address:
         name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
         type:PostalAddress
      name:The Institute of Cancer Research
      address:
         name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
         type:PostalAddress
      name:Biostatistics, Janssen Research & Development
      address:
         name:Biostatistics, Janssen Research & Development, Spring House, USA
         type:PostalAddress
      name:Oncology, Janssen Biologics, B.V.
      address:
         name:Oncology, Janssen Biologics, B.V., Leiden, The Netherlands
         type:PostalAddress
      name:Janssen Research & Development
      address:
         name:Biologics Clinical Pharmacology, Janssen Research & Development, Spring House, USA
         type:PostalAddress
      name:Queen Mary University of London
      address:
         name:Barts Cancer Institute, Queen Mary University of London, London, UK
         type:PostalAddress
      name:Global Regulatory Affairs
      address:
         name:Global Regulatory Affairs, High Wycombe, UK
         type:PostalAddress
      name:Janssen Research & Development
      address:
         name:Biomarker Oncology, Janssen Research & Development, Spring House, USA
         type:PostalAddress
      name:The Institute of Cancer Research
      address:
         name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
         type:PostalAddress
      name:START Center for Cancer Care
      address:
         name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Shahneen K. Sandhu
      affiliation:
            name:The Institute of Cancer Research
            address:
               name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
               type:PostalAddress
            type:Organization
      name:Kyri Papadopoulos
      affiliation:
            name:START Center for Cancer Care
            address:
               name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
               type:PostalAddress
            type:Organization
      name:Peter C. Fong
      affiliation:
            name:The Institute of Cancer Research
            address:
               name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
               type:PostalAddress
            type:Organization
      name:Amita Patnaik
      affiliation:
            name:START Center for Cancer Care
            address:
               name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
               type:PostalAddress
            type:Organization
      name:Christina Messiou
      affiliation:
            name:The Institute of Cancer Research
            address:
               name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
               type:PostalAddress
            type:Organization
      name:David Olmos
      affiliation:
            name:The Institute of Cancer Research
            address:
               name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
               type:PostalAddress
            type:Organization
      name:George Wang
      affiliation:
            name:Biostatistics, Janssen Research & Development
            address:
               name:Biostatistics, Janssen Research & Development, Spring House, USA
               type:PostalAddress
            type:Organization
      name:Brenda J. Tromp
      affiliation:
            name:Oncology, Janssen Biologics, B.V.
            address:
               name:Oncology, Janssen Biologics, B.V., Leiden, The Netherlands
               type:PostalAddress
            type:Organization
      name:Thomas A. Puchalski
      affiliation:
            name:Janssen Research & Development
            address:
               name:Biologics Clinical Pharmacology, Janssen Research & Development, Spring House, USA
               type:PostalAddress
            type:Organization
      name:Frances Balkwill
      affiliation:
            name:Queen Mary University of London
            address:
               name:Barts Cancer Institute, Queen Mary University of London, London, UK
               type:PostalAddress
            type:Organization
      name:Birge Berns
      affiliation:
            name:Global Regulatory Affairs
            address:
               name:Global Regulatory Affairs, High Wycombe, UK
               type:PostalAddress
            type:Organization
      name:Shobha Seetharam
      affiliation:
            name:Janssen Research & Development
            address:
               name:Biomarker Oncology, Janssen Research & Development, Spring House, USA
               type:PostalAddress
            type:Organization
      name:Johann S. de Bono
      affiliation:
            name:The Institute of Cancer Research
            address:
               name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Anthony W. Tolcher
      affiliation:
            name:START Center for Cancer Care
            address:
               name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
      name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
      name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
      name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
      name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
      name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
      name:Biostatistics, Janssen Research & Development, Spring House, USA
      name:Oncology, Janssen Biologics, B.V., Leiden, The Netherlands
      name:Biologics Clinical Pharmacology, Janssen Research & Development, Spring House, USA
      name:Barts Cancer Institute, Queen Mary University of London, London, UK
      name:Global Regulatory Affairs, High Wycombe, UK
      name:Biomarker Oncology, Janssen Research & Development, Spring House, USA
      name:Drug Development Unit, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Surrey, UK
      name:South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(164)

• How much profit does https://www.springernature.com/gp/authors generate?
• How much does https://link.springernature.com/home/ pull in?
• What's https://order.springer.com/public/cart's gross income?
• Monthly income for https://submission.springernature.com/new-submission/280/3
• How profitable is https://www.springernature.com/gp/librarians/licensing/agc/journals?
• How much revenue does https://doi.org/10.1089/jir.2008.0027 generate?
• Monthly income for https://doi.org/10.1089%2Fjir.2008.0027
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19441883?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Monocyte%20chemoattractant%20protein-1%20%28MCP-1%29%3A%20an%20overview&journal=J%20Interferon%20Cytokine%20Res&doi=10.1089%2Fjir.2008.0027&volume=29&issue=6&pages=313-326&publication_year=2009&author=Deshmane%2CSL&author=Kremlev%2CS&author=Amini%2CS&author=Sawaya%2CBE
• Learn about the earnings of https://doi.org/10.1007/s10555-006-9027-x
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17160712
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=CCL2%20%28Monocyte%20Chemoattractant%20Protein-1%29%20in%20cancer%20bone%20metastases&journal=Cancer%20Metastasis%20Rev&doi=10.1007%2Fs10555-006-9027-x&volume=25&issue=4&pages=611-619&publication_year=2006&author=Craig%2CMJ&author=Loberg%2CRD each month?
• What is the monthly revenue of https://doi.org/10.1016/j.molmed.2010.01.003?
• How much revenue does https://doi.org/10.1016%2Fj.molmed.2010.01.003 generate?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20163989 is on a monthly basis
• How much does http://scholar.google.com/scholar_lookup?&title=Chemokines%20and%20chemokine%20receptors%3A%20new%20insights%20into%20cancer-related%20inflammation&journal=Trends%20Mol%20Med&doi=10.1016%2Fj.molmed.2010.01.003&volume=16&issue=3&pages=133-144&publication_year=2010&author=Lazennec%2CG&author=Richmond%2CA rake in every month?
• Monthly income for https://doi.org/10.1038/nature10138
• What is the earnings of https://doi.org/10.1038%2Fnature10138?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21654748
• http://scholar.google.com/scholar_lookup?&title=CCL2%20recruits%20inflammatory%20monocytes%20to%20facilitate%20breast-tumour%20metastasis&journal=Nature&doi=10.1038%2Fnature10138&volume=475&issue=7355&pages=222-225&publication_year=2011&author=Qian%2CBZ&author=Li%2CJ&author=Zhang%2CH&author=Kitamura%2CT&author=Zhang%2CJ&author=Campion%2CLR&author=Kaiser%2CEA&author=Snyder%2CLA&author=Pollard%2CJW's financial summary
• Profit of https://doi.org/10.1002/jcb.21652
• Check the income stats for https://doi.org/10.1002%2Fjcb.21652
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18646053
• Earnings of http://scholar.google.com/scholar_lookup?&title=CCL2%20induces%20prostate%20cancer%20transendothelial%20cell%20migration%20via%20activation%20of%20the%20small%20GTPase%20Rac&journal=J%20Cell%20Biochem&doi=10.1002%2Fjcb.21652&volume=104&issue=5&pages=1587-1597&publication_year=2008&author=Golen%2CKL&author=Ying%2CC&author=Sequeira%2CL&author=Dubyk%2CCW&author=Reisenberger%2CT&author=Chinnaiyan%2CAM&author=Pienta%2CKJ&author=Loberg%2CRD
• How profitable is https://doi.org/10.1093/jnci/djq044?
• Get to know https://doi.org/10.1093%2Fjnci%2Fdjq044's earnings
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20233997 make?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Multiple%20roles%20of%20chemokine%20%28C%E2%80%93C%20motif%29%20ligand%202%20in%20promoting%20prostate%20cancer%20growth&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjq044&volume=102&issue=8&pages=522-528&publication_year=2010&author=Zhang%2CJ&author=Lu%2CY&author=Pienta%2CKJ produce monthly?
• Income figures for https://doi.org/10.1016/j.cytogfr.2009.11.009
• What's the income generated by https://doi.org/10.1016%2Fj.cytogfr.2009.11.009 each month?
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20005149?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=CC%20chemokine%20ligand%202%20%28CCL2%29%20promotes%20prostate%20cancer%20tumorigenesis%20and%20metastasis&journal=Cytokine%20Growth%20Factor%20Rev&doi=10.1016%2Fj.cytogfr.2009.11.009&volume=21&issue=1&pages=41-48&publication_year=2010&author=Zhang%2CJ&author=Patel%2CL&author=Pienta%2CKJ?
• Find out how much https://doi.org/10.1158/0008-5472.CAN-06-1210 earns monthly
• How much does https://doi.org/10.1158%2F0008-5472.CAN-06-1210 pull in monthly?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17440076
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Monocyte%20chemotactic%20protein-1%20mediates%20prostate%20cancer-induced%20bone%20resorption&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-1210&volume=67&issue=8&pages=3646-3653&publication_year=2007&author=Lu%2CY&author=Cai%2CZ&author=Xiao%2CG&author=Keller%2CET&author=Mizokami%2CA&author=Yao%2CZ&author=Roodman%2CGD&author=Zhang%2CJ?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19881959 produce monthly?
• How much money does http://scholar.google.com/scholar_lookup?&title=The%20chemokine%20CCL2%20increases%20prostate%20tumor%20growth%20and%20bone%20metastasis%20through%20macrophage%20and%20osteoclast%20recruitment&journal=Neoplasia&volume=11&issue=11&pages=1235-1242&publication_year=2009&author=Mizutani%2CK&author=Sud%2CS&author=McGregor%2CNA&author=Martinovski%2CG&author=Rice%2CBT&author=Craig%2CMJ&author=Varsos%2CZS&author=Roca%2CH&author=Pienta%2CKJ generate?
• How much does https://doi.org/10.1074/jbc.M801073200 generate monthly?
• Profit of https://doi.org/10.1074%2Fjbc.M801073200
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18611860?
• How much money does http://scholar.google.com/scholar_lookup?&title=CCL2%20protects%20prostate%20cancer%20PC3%20cells%20from%20autophagic%20death%20via%20phosphatidylinositol%203-kinase%2FAKT-dependent%20survivin%20up-regulation&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M801073200&volume=283&issue=36&pages=25057-25073&publication_year=2008&author=Roca%2CH&author=Varsos%2CZ&author=Pienta%2CKJ generate?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2182712 generate?
• http://scholar.google.com/scholar_lookup?&title=Monocyte%20chemotactic%20and%20activating%20factor%20gene%20expression%20induced%20in%20endothelial%20cells%20by%20IL-1%20and%20tumor%20necrosis%20factor&journal=J%20Immunol&volume=144&issue=8&pages=3034-3038&publication_year=1990&author=Sica%2CA&author=Wang%2CJM&author=Colotta%2CF&author=Dejana%2CE&author=Mantovani%2CA&author=Oppenheim%2CJJ&author=Larsen%2CCG&author=Zachariae%2CCO&author=Matsushima%2CK's total income per month
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10823415 earning monthly?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Macrophage%20infiltration%20in%20human%20non-small-cell%20lung%20cancer%3A%20the%20role%20of%20CC%20chemokines&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs002620050603&volume=49&issue=2&pages=63-70&publication_year=2000&author=Arenberg%2CDA&author=Keane%2CMP&author=DiGiovine%2CB&author=Kunkel%2CSL&author=Strom%2CSR&author=Burdick%2CMD&author=Iannettoni%2CMD&author=Strieter%2CRM?
• What's the financial intake of https://doi.org/10.1038/sj.bjc.6690776?
• How much does https://doi.org/10.1038%2Fsj.bjc.6690776 earn?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10555758's revenue stream
• How much profit is http://scholar.google.com/scholar_lookup?&title=Monocyte%20chemoattractant%20protein-1%20serum%20levels%20in%20ovarian%20cancer%20patients&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6690776&volume=81&issue=5&pages=855-859&publication_year=1999&author=Hefler%2CL&author=Tempfer%2CC&author=Heinze%2CG&author=Mayerhofer%2CK&author=Breitenecker%2CG&author=Leodolter%2CS&author=Reinthaller%2CA&author=Kainz%2CC making per month?
• Learn how profitable https://doi.org/10.1111/j.1572-0241.2004.30733.x is on a monthly basis
• How much does https://doi.org/10.1111%2Fj.1572-0241.2004.30733.x rake in every month?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15330899 bring in?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Significance%20of%20macrophage%20chemoattractant%20protein-1%20expression%20and%20macrophage%20infiltration%20in%20squamous%20cell%20carcinoma%20of%20the%20esophagus&journal=Am%20J%20Gastroenterol&doi=10.1111%2Fj.1572-0241.2004.30733.x&volume=99&issue=9&pages=1667-1674&publication_year=2004&author=Koide%2CN&author=Nishio%2CA&author=Sato%2CT&author=Sugiyama%2CA&author=Miyagawa%2CS
• What's the total monthly financial gain of https://doi.org/10.1593/neo.06280?
• Get to know https://doi.org/10.1593%2Fneo.06280's earnings
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16867220's financial summary
• How much income is http://scholar.google.com/scholar_lookup?&title=CCL2%20is%20a%20potent%20regulator%20of%20prostate%20cancer%20cell%20migration%20and%20proliferation&journal=Neoplasia&doi=10.1593%2Fneo.06280&volume=8&issue=7&pages=578-586&publication_year=2006&author=Loberg%2CRD&author=Day%2CLL&author=Harwood%2CJ&author=Ying%2CC&author=St%20John%2CLN&author=Giles%2CR&author=Neeley%2CCK&author=Pienta%2CKJ earning monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14612545 bring in each month?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=The%20CC%20chemokine%20MCP-1%2FCCL2%20in%20pancreatic%20cancer%20progression%3A%20regulation%20of%20expression%20and%20potential%20mechanisms%20of%20antimalignant%20activity&journal=Cancer%20Res&volume=63&issue=21&pages=7451-7461&publication_year=2003&author=Monti%2CP&author=Leone%2CBE&author=Marchesi%2CF&author=Balzano%2CG&author=Zerbi%2CA&author=Scaltrini%2CF&author=Pasquali%2CC&author=Calori%2CG&author=Pessi%2CF&author=Sperti%2CC&author=Carlo%2CV&author=Allavena%2CP&author=Piemonti%2CL
• What's the revenue for https://doi.org/10.1002/ijc.10705?
• What is the monthly revenue of https://doi.org/10.1002%2Fijc.10705?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12397639 net monthly?
• How much income does http://scholar.google.com/scholar_lookup?&title=Monocyte%20chemoattractant%20protein-1%20expression%20correlates%20with%20macrophage%20infiltration%20and%20tumor%20vascularity%20in%20human%20esophageal%20squamous%20cell%20carcinomas&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.10705&volume=102&issue=3&pages=220-224&publication_year=2002&author=Ohta%2CM&author=Kitadai%2CY&author=Tanaka%2CS&author=Yoshihara%2CM&author=Yasui%2CW&author=Mukaida%2CN&author=Haruma%2CK&author=Chayama%2CK have?
• https://doi.org/10.1002/1097-0142(20010901)92:5%3c1085:AID-CNCR1424%3e3.0.CO;2-K income
• How much revenue does https://doi.org/10.1002%2F1097-0142%2820010901%2992%3A5%3C1085%3A%3AAID-CNCR1424%3E3.0.CO%3B2-K produce monthly?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11571719?
• http://scholar.google.com/scholar_lookup?&title=Significant%20correlation%20of%20monocyte%20chemoattractant%20protein-1%20expression%20with%20neovascularization%20and%20progression%20of%20breast%20carcinoma&journal=Cancer&doi=10.1002%2F1097-0142%2820010901%2992%3A5%3C1085%3A%3AAID-CNCR1424%3E3.0.CO%3B2-K&volume=92&issue=5&pages=1085-1091&publication_year=2001&author=Saji%2CH&author=Koike%2CM&author=Yamori%2CT&author=Saji%2CS&author=Seiki%2CM&author=Matsushima%2CK&author=Toi%2CM's total income per month
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10955814?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Significance%20of%20macrophage%20chemoattractant%20protein-1%20in%20macrophage%20recruitment%2C%20angiogenesis%2C%20and%20survival%20in%20human%20breast%20cancer&journal=Clin%20Cancer%20Res&volume=6&issue=8&pages=3282-3289&publication_year=2000&author=Ueno%2CT&author=Toi%2CM&author=Saji%2CH&author=Muta%2CM&author=Bando%2CH&author=Kuroi%2CK&author=Koike%2CM&author=Inadera%2CH&author=Matsushima%2CK
• How much does https://doi.org/10.1593%2Fneo.07307 net monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17710158 make?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=CCL2%20as%20an%20important%20mediator%20of%20prostate%20cancer%20growth%20in%20vivo%20through%20the%20regulation%20of%20macrophage%20infiltration&journal=Neoplasia&doi=10.1593%2Fneo.07307&volume=9&issue=7&pages=556-562&publication_year=2007&author=Loberg%2CRD&author=Ying%2CC&author=Craig%2CM&author=Yan%2CL&author=Snyder%2CLA&author=Pienta%2CKJ?
• How much profit does https://doi.org/10.1158/0008-5472.CAN-08-2164 make?
• Learn about the earnings of https://doi.org/10.1158%2F0008-5472.CAN-08-2164
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19176388 pull in?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=A%20destructive%20cascade%20mediated%20by%20CCL2%20facilitates%20prostate%20cancer%20growth%20in%20bone&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-08-2164&volume=69&issue=4&pages=1685-1692&publication_year=2009&author=Li%2CX&author=Loberg%2CR&author=Liao%2CJ&author=Ying%2CC&author=Snyder%2CLA&author=Pienta%2CKJ&author=McCauley%2CLK
• How much revenue does https://doi.org/10.1158/0008-5472.CAN-07-1286 generate?
• How much does https://doi.org/10.1158%2F0008-5472.CAN-07-1286 net monthly?
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17909051?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Targeting%20CCL2%20with%20systemic%20delivery%20of%20neutralizing%20antibodies%20induces%20prostate%20cancer%20tumor%20regression%20in%20vivo&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-07-1286&volume=67&issue=19&pages=9417-9424&publication_year=2007&author=Loberg%2CRD&author=Ying%2CC&author=Craig%2CM&author=Day%2CLL&author=Sargent%2CE&author=Neeley%2CC&author=Wojno%2CK&author=Snyder%2CLA&author=Yan%2CL&author=Pienta%2CKJ
• What's the total monthly financial gain of https://doi.org/10.1093/jnci/djp079?
• How much money does https://doi.org/10.1093%2Fjnci%2Fdjp079 make?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19436029 bring in each month?
• How much does http://scholar.google.com/scholar_lookup?&title=Dose%20escalation%20methods%20in%20phase%20I%20cancer%20clinical%20trials&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjp079&volume=101&issue=10&pages=708-720&publication_year=2009&author=Tourneau%2CC&author=Lee%2CJJ&author=Siu%2CLL bring in each month?
• How much revenue does https://doi.org/10.1093%2Fjnci%2F92.3.205 produce monthly?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10655437's revenue stream
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=New%20guidelines%20to%20evaluate%20the%20response%20to%20treatment%20in%20solid%20tumors.%20European%20Organization%20for%20Research%20and%20Treatment%20of%20Cancer%2C%20National%20Cancer%20Institute%20of%20the%20United%20States%2C%20National%20Cancer%20Institute%20of%20Canada&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F92.3.205&volume=92&issue=3&pages=205-216&publication_year=2000&author=Therasse%2CP&author=Arbuck%2CSG&author=Eisenhauer%2CEA&author=Wanders%2CJ&author=Kaplan%2CRS&author=Rubinstein%2CL&author=Verweij%2CJ&author=Glabbeke%2CM&author=Oosterom%2CAT&author=Christian%2CMC&author=Gwyther%2CSG
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10550143?
• How much does http://scholar.google.com/scholar_lookup?&title=Eligibility%20and%20response%20guidelines%20for%20phase%20II%20clinical%20trials%20in%20androgen-independent%20prostate%20cancer%3A%20recommendations%20from%20the%20Prostate-Specific%20Antigen%20Working%20Group&journal=J%20Clin%20Oncol&volume=17&issue=11&pages=3461-3467&publication_year=1999&author=Bubley%2CGJ&author=Carducci%2CM&author=Dahut%2CW&author=Dawson%2CN&author=Daliani%2CD&author=Eisenberger%2CM&author=Figg%2CWD&author=Freidlin%2CB&author=Halabi%2CS&author=Hudes%2CG&author=Hussain%2CM&author=Kaplan%2CR&author=Myers%2CC&author=Oh%2CW&author=Petrylak%2CDP&author=Reed%2CE&author=Roth%2CB&author=Sartor%2CO&author=Scher%2CH&author=Simons%2CJ&author=Sinibaldi%2CV&author=Small%2CEJ&author=Smith%2CMR&author=Trump%2CDL&author=Wilding%2CG net monthly?
• What's the monthly income of https://doi.org/10.1093%2Fjnci%2Fdjh081?
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15026475
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Re%3A%20new%20guidelines%20to%20evaluate%20the%20response%20to%20treatment%20in%20solid%20tumors%20%28ovarian%20cancer%29&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjh081&volume=96&issue=6&pages=487-488&publication_year=2004&author=Rustin%2CGJ&author=Quinn%2CM&author=Thigpen%2CT&author=Bois%2CA&author=Pujade-Lauraine%2CE&author=Jakobsen%2CA&author=Eisenhauer%2CE&author=Sagae%2CS&author=Greven%2CK&author=Vergote%2CI&author=Cervantes%2CA&author=Vermorken%2CJ each month?
• What's the monthly income of https://doi.org/10.1158/1078-0432.CCR-07-1506?
• How much does https://doi.org/10.1158%2F1078-0432.CCR-07-1506 generate monthly?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18056182 generate?
• http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cell%20number%20and%20prognosis%20in%20progressive%20castration-resistant%20prostate%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1506&volume=13&issue=23&pages=7053-7058&publication_year=2007&author=Danila%2CDC&author=Heller%2CG&author=Gignac%2CGA&author=Gonzalez-Espinoza%2CR&author=Anand%2CA&author=Tanaka%2CE&author=Lilja%2CH&author=Schwartz%2CL&author=Larson%2CS&author=Fleisher%2CM&author=Scher%2CHI's total income per month
• Find out how much https://doi.org/10.1158/1078-0432.CCR-08-0872 earns monthly
• Monthly income for https://doi.org/10.1158%2F1078-0432.CCR-08-0872
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18829513?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%20predict%20survival%20benefit%20from%20treatment%20in%20metastatic%20castration-resistant%20prostate%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-08-0872&volume=14&issue=19&pages=6302-6309&publication_year=2008&author=Bono%2CJS&author=Scher%2CHI&author=Montgomery%2CRB&author=Parker%2CC&author=Miller%2CMC&author=Tissing%2CH&author=Doyle%2CGV&author=Terstappen%2CLW&author=Pienta%2CKJ&author=Raghavan%2CD?
• Find out how much https://doi.org/10.1200/JCO.2011.37.3472 earns monthly
• How much profit does https://doi.org/10.1200%2FJCO.2011.37.3472 make?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22312108 make?
• Income figures for http://scholar.google.com/scholar_lookup?&title=Defucosylated%20anti-CCR4%20monoclonal%20antibody%20%28KW-0761%29%20for%20relapsed%20adult%20T-cell%20leukemia-lymphoma%3A%20a%20multicenter%20phase%20II%20study&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2011.37.3472&volume=30&issue=8&pages=837-842&publication_year=2012&author=Ishida%2CT&author=Joh%2CT&author=Uike%2CN&author=Yamamoto%2CK&author=Utsunomiya%2CA&author=Yoshida%2CS&author=Saburi%2CY&author=Miyamoto%2CT&author=Takemoto%2CS&author=Suzushima%2CH&author=Tsukasaki%2CK&author=Nosaka%2CK&author=Fujiwara%2CH&author=Ishitsuka%2CK&author=Inagaki%2CH&author=Ogura%2CM&author=Akinaga%2CS&author=Tomonaga%2CM&author=Tobinai%2CK&author=Ueda%2CR
• Earnings of https://doi.org/10.1200/JCO.2009.25.3575
• Discover the revenue of https://doi.org/10.1200%2FJCO.2009.25.3575
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20177026's total income per month
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Phase%20I%20study%20of%20KW-0761%2C%20a%20defucosylated%20humanized%20anti-CCR4%20antibody%2C%20in%20relapsed%20patients%20with%20adult%20T-cell%20leukemia-lymphoma%20and%20peripheral%20T-cell%20lymphoma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.25.3575&volume=28&issue=9&pages=1591-1598&publication_year=2010&author=Yamamoto%2CK&author=Utsunomiya%2CA&author=Tobinai%2CK&author=Tsukasaki%2CK&author=Uike%2CN&author=Uozumi%2CK&author=Yamaguchi%2CK&author=Yamada%2CY&author=Hanada%2CS&author=Tamura%2CK&author=Nakamura%2CS&author=Inagaki%2CH&author=Ohshima%2CK&author=Kiyoi%2CH&author=Ishida%2CT&author=Matsushima%2CK&author=Akinaga%2CS&author=Ogura%2CM&author=Tomonaga%2CM&author=Ueda%2CR?
• See how much https://doi.org/10.1002/art.21975 makes per month
• Get to know what's the income of https://doi.org/10.1002%2Fart.21975
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16869001 make?
• How much does http://scholar.google.com/scholar_lookup?&title=A%20randomized%20controlled%20trial%20with%20an%20anti-CCL2%20%28anti-monocyte%20chemotactic%20protein%201%29%20monoclonal%20antibody%20in%20patients%20with%20rheumatoid%20arthritis&journal=Arthritis%20Rheum&doi=10.1002%2Fart.21975&volume=54&issue=8&pages=2387-2392&publication_year=2006&author=Haringman%2CJJ&author=Gerlag%2CDM&author=Smeets%2CTJ&author=Baeten%2CD&author=Bosch%2CF&author=Bresnihan%2CB&author=Breedveld%2CFC&author=Dinant%2CHJ&author=Legay%2CF&author=Gram%2CH&author=Loetscher%2CP&author=Schmouder%2CR&author=Woodworth%2CT&author=Tak%2CPP earn?
• How much revenue does https://doi.org/10.1002/art.23591 produce monthly?
• How much revenue does https://doi.org/10.1002%2Fart.23591 produce monthly?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18576354
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Modulation%20of%20CCR2%20in%20rheumatoid%20arthritis%3A%20a%20double-blind%2C%20randomized%2C%20placebo-controlled%20clinical%20trial&journal=Arthritis%20Rheum&doi=10.1002%2Fart.23591&volume=58&issue=7&pages=1931-1939&publication_year=2008&author=Vergunst%2CCE&author=Gerlag%2CDM&author=Lopatinskaya%2CL&author=Klareskog%2CL&author=Smith%2CMD&author=Bosch%2CF&author=Dinant%2CHJ&author=Lee%2CY&author=Wyant%2CT&author=Jacobson%2CEW&author=Baeten%2CD&author=Tak%2CPP
• What are the total earnings of https://citation-needed.springer.com/v2/references/10.1007/s00280-013-2099-8?format=refman&flavour=references?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shahneen%20K.%20Sandhu produce monthly?
• How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shahneen%20K.%20Sandhu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
• Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kyri%20Papadopoulos
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kyri%20Papadopoulos%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Peter%20C.%20Fong?
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Peter%20C.%20Fong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Amita%20Patnaik generate?
• Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Amita%20Patnaik%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christina%20Messiou earns monthly
• What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christina%20Messiou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=David%20Olmos
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22David%20Olmos%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=George%20Wang make?
• See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22George%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Brenda%20J.%20Tromp's total income per month
• Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Brenda%20J.%20Tromp%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Thomas%20A.%20Puchalski have?
• Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Thomas%20A.%20Puchalski%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Frances%20Balkwill make?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Frances%20Balkwill%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
• What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Birge%20Berns?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Birge%20Berns%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
• What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shobha%20Seetharam?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shobha%20Seetharam%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
• What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Johann%20S.%20de%20Bono?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Johann%20S.%20de%20Bono%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
• What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anthony%20W.%20Tolcher?
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anthony%20W.%20Tolcher%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://s100.copyright.com/AppDispatchServlet?title=A%20first-in-human%2C%20first-in-class%2C%20phase%20I%20study%20of%20carlumab%20%28CNTO%20888%29%2C%20a%20human%20monoclonal%20antibody%20against%20CC-chemokine%20ligand%202%20in%20patients%20with%20solid%20tumors&author=Shahneen%20K.%20Sandhu%20et%20al&contentID=10.1007%2Fs00280-013-2099-8©right=Springer-Verlag%20Berlin%20Heidelberg&publication=0344-5704&publicationDate=2013-02-06&publisherName=SpringerNature&orderBeanReset=true pull in?
• What's the financial intake of https://citation-needed.springer.com/v2/references/10.1007/s00280-013-2099-8?format=refman&flavour=citation?
• What's the income generated by https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral each month?
• Monthly income for https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
• Explore the financials of https://www.springernature.com/gp/products
• Profit of https://www.springernature.com/gp/librarians
• How much profit does https://www.springernature.com/gp/societies generate?
• How much does https://www.springernature.com/gp/partners bring in each month?
• What's the revenue for https://www.springer.com/?
• How much does https://www.nature.com/ rake in every month?
• How much does https://www.biomedcentral.com/ earn?
• https://www.palgrave.com/'s revenue stream
• How much profit is https://www.apress.com/ making per month?
• How much revenue does https://www.springernature.com/gp/legal/ccpa generate?
• Discover the revenue of https://www.springernature.com/gp/info/accessibility
• https://support.springernature.com/en/support/home's total income per month
• How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations pull in?
• Discover the revenue of https://www.springernature.com/

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref